Back to the library
Growth hormone signaling
CJC-1295
Human trialsResearch education only. This profile does not establish benefits or safety for personal use.
EvidenceHuman trials
Curated studies1
Research areaGrowth hormone signaling
At a glance
A long-acting growth hormone-releasing hormone analogue studied through early human hormone measurements.
How it is studied
Stimulates the GHRH axis. Product names such as “no DAC” may refer to chemically different materials.
Evidence & studies 1 curated
Read the population, methods, and limitations alongside each outcome. This selection is a starting point, not a systematic review.
Human early-phase trial · 2006Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295 in healthy adults
Read summary & limitationsRisks & limits
- Clinical benefit and long-term safety are not established by the evidence curated here.
- Identity, purity, formulation, and route affect risk; a research label is not evidence of suitability for human use.
No universal storage, reconstitution, or administration protocol is provided. Product-specific instructions and evidence must be established separately.